Support For Stewart, Feder

The fight over Walter Stewart and Ned Feder (Franklin Hoke, The Scientist, May 17, 1993, page 1) is not about plagiarism by a historian, nor about scientific fraud. It is about power. Since World War II, the United States government has given money to biomedical science and let the scientists carve it up among themselves. The system rewards favor-trading, so politicians arose, the skilled ones achieving great influence over funding. Influence and fear permeate our profession. Disagree with

Written byCharles Mccutchen
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The fight over Walter Stewart and Ned Feder (Franklin Hoke, The Scientist, May 17, 1993, page 1) is not about plagiarism by a historian, nor about scientific fraud. It is about power. Since World War II, the United States government has given money to biomedical science and let the scientists carve it up among themselves. The system rewards favor-trading, so politicians arose, the skilled ones achieving great influence over funding.

Influence and fear permeate our profession. Disagree with a top figure in your field, and you may be unpublished and grantless.

When someone blows a whistle, the truth of the charge comes second. What counts is whether it offends the powerful. The system sees the mere act of whistle-blowing as disrespect. (Margot O'Toole got a violent response from the elite because she, a postdoc, did not know her place.)

The charge, whatever it is, will be found wanting, and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies